New drug tested in people with liver disease
NCT ID NCT06957756
First seen Feb 21, 2026 · Last updated May 23, 2026 · Updated 17 times
Summary
This study looks at how different levels of liver disease affect the way the body handles a new medicine called BI 1584862. About 43 adults, some with mild to severe liver problems and some with healthy livers, will take a single dose of the drug. Researchers will check safety and measure drug levels in the blood over several weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC INSUFFICIENCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
American Research Corporation
San Antonio, Texas, 78215, United States
-
Arizona Clinical Trials - Chandler
Chandler, Arizona, 85225, United States
-
Omega Research Orlando, LLC
Orlando, Florida, 32808, United States
Conditions
Explore the condition pages connected to this study.